Edgestream Partners L.P. Invests $679,000 in ICU Medical, Inc. (NASDAQ:ICUI)

Edgestream Partners L.P. acquired a new stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 4,374 shares of the medical instruments supplier's stock, valued at approximately $679,000.

Other hedge funds also recently made changes to their positions in the company. Arizona State Retirement System raised its holdings in shares of ICU Medical by 1.0% during the 4th quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock worth $1,044,000 after acquiring an additional 65 shares in the last quarter. Equitable Trust Co. raised its holdings in shares of ICU Medical by 1.6% during the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock worth $822,000 after acquiring an additional 84 shares in the last quarter. Connable Office Inc. raised its holdings in shares of ICU Medical by 6.4% during the 3rd quarter. Connable Office Inc. now owns 2,031 shares of the medical instruments supplier's stock worth $370,000 after acquiring an additional 122 shares in the last quarter. Gagnon Securities LLC raised its holdings in shares of ICU Medical by 0.5% during the 4th quarter. Gagnon Securities LLC now owns 28,881 shares of the medical instruments supplier's stock worth $4,481,000 after acquiring an additional 137 shares in the last quarter. Finally, Wealthspire Advisors LLC raised its holdings in shares of ICU Medical by 6.4% during the 4th quarter. Wealthspire Advisors LLC now owns 2,660 shares of the medical instruments supplier's stock worth $413,000 after acquiring an additional 160 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors.

Remove Ads

Insider Buying and Selling at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the company's stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the transaction, the chief executive officer now owns 104,593 shares of the company's stock, valued at $16,262,119.64. This represents a 1.30 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 6.70% of the stock is currently owned by corporate insiders.

ICU Medical Trading Up 2.3 %

ICU Medical stock traded up $3.26 during mid-day trading on Friday, hitting $143.45. The company's stock had a trading volume of 190,275 shares, compared to its average volume of 233,538. The company has a 50 day moving average of $157.27 and a 200-day moving average of $164.95. The stock has a market cap of $3.52 billion, a PE ratio of -31.39 and a beta of 0.73. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. ICU Medical, Inc. has a one year low of $93.36 and a one year high of $196.26.

Analyst Ratings Changes

ICUI has been the topic of several recent research reports. Raymond James set a $97.00 price objective on ICU Medical in a report on Wednesday. Jefferies Financial Group upgraded ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target on the stock in a report on Wednesday, December 11th. Finally, StockNews.com lowered ICU Medical from a "buy" rating to a "hold" rating in a report on Monday, March 10th. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $168.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.